HER2-Positive Breast Cancer: 1ed
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.
- Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
- Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.
- Includes a timely section on innovative future therapies.
| Book | |
|---|---|
| Author | Hurvitz, Sara |
| Pages | 264 |
| Year | 2018 |
| ISBN | 9780323581226 |
| Publisher | Elsevier |
| Language | English |
| Uncategorized | |
| Edition | 1/e |
| Weight | 660 g |
| Dimensions | 19.69 x 24 x 1.27 cm |
| Binding | Paperback |